These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21175264)

  • 21. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
    Tabasi SH; Moolchandani V; Fahmy R; Hoag SW
    Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface responses and desirability functions to determine optimal granulation domains.
    Giry K; Viana M; Genty M; Wüthrich P; Chulia D
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1016-26. PubMed ID: 20818964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of sustained release matrix pellets by melt agglomeration in the fluidized bed: influence of formulation variables and modelling of agglomerate growth.
    Pauli-Bruns A; Knop K; Lippold BC
    Eur J Pharm Biopharm; 2010 Mar; 74(3):503-12. PubMed ID: 20026401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation.
    Dévay A; Mayer K; Pál S; Antal I
    J Biochem Biophys Methods; 2006 Nov; 69(1-2):197-205. PubMed ID: 16650480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A flexible technology for modified-release drugs: multiple-unit pellet system (MUPS).
    Abdul S; Chandewar AV; Jaiswal SB
    J Control Release; 2010 Oct; 147(1):2-16. PubMed ID: 20493217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose.
    Sugimoto M; Narisawa S; Matsubara K; Yoshino H; Nakano M; Handa T
    Int J Pharm; 2006 Aug; 320(1-2):71-8. PubMed ID: 16750604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microscale granulation in a fluid bed powder processor using electrostatic atomisation.
    Kivikero N; Murtomaa M; Ingelbeen B; Antikainen O; Räsänen E; Mannermaa JP; Juppo AM
    Eur J Pharm Biopharm; 2009 Jan; 71(1):130-7. PubMed ID: 18703138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase transformation considerations during process development and manufacture of solid oral dosage forms.
    Zhang GG; Law D; Schmitt EA; Qiu Y
    Adv Drug Deliv Rev; 2004 Feb; 56(3):371-90. PubMed ID: 14962587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focused beam reflectance method as an innovative (PAT) tool to monitor in-line granulation process in fluidized bed.
    Alshihabi F; Vandamme T; Betz G
    Pharm Dev Technol; 2013 Feb; 18(1):73-84. PubMed ID: 22035287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pellet technology. Sustained-release pellets in hard gelatin capsules--a suitable dosage form for theophylline].
    Laicher A; Fuchs WS
    Arzneimittelforschung; 1998 May; 48(5A):540-7. PubMed ID: 9676341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous release of diclofenac sodium and papaverine hydrochloride from tablets and pellets using the flow-through cell apparatus described by dimensionless equations.
    Kasperek R
    Acta Pol Pharm; 2011; 68(2):261-72. PubMed ID: 21485300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension].
    Weiss G; Klemm FH; Fuchs WS; Stanislaus F; Zema M; Calanchi M
    Arzneimittelforschung; 1998 May; 48(5A):604-12. PubMed ID: 9676353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrusion-spheronization manufacture of Gelucire matrix beads.
    Montoussé C; Pruvost M; Rodriguez F; Brossard C
    Drug Dev Ind Pharm; 1999 Jan; 25(1):75-80. PubMed ID: 10028421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET; Cadé D; Benameur H
    Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlling granule size by granulation liquid feed pulsing.
    Närvänen T; Lipsanen T; Antikainen O; Räikkönen H; Yliruusi J
    Int J Pharm; 2008 Jun; 357(1-2):132-8. PubMed ID: 18343060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanistic modelling of fluidized bed drying processes of wet porous granules: a review.
    Mortier ST; De Beer T; Gernaey KV; Remon JP; Vervaet C; Nopens I
    Eur J Pharm Biopharm; 2011 Oct; 79(2):205-25. PubMed ID: 21664970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Power consumption measurement and temperature recording during granulation.
    Betz G; Bürgin PJ; Leuenberger H
    Int J Pharm; 2004 Mar; 272(1-2):137-49. PubMed ID: 15019077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relevance of air-to-liquid mass ratio effect on final granule properties of an Enalapril maleate formulation.
    Hartung A; Knoell M; Schmidt U; Langguth P
    Drug Dev Ind Pharm; 2012 Jan; 38(1):12-8. PubMed ID: 21721850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining microwave resonance technology to multivariate data analysis as a novel PAT tool to improve process understanding in fluid bed granulation.
    Lourenço V; Herdling T; Reich G; Menezes JC; Lochmann D
    Eur J Pharm Biopharm; 2011 Aug; 78(3):513-21. PubMed ID: 21333737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.